Dimitri E. Grigoriadis, Chief Research Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 23,022 shares at $110.00 ($2.5M) on 2018-08-01, disclosed to the SEC on 2018-08-03.
Open-market sale of $2.5M NBIX by Chief Research Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2020-11-16 | $410K | — | Filing → |
| NBIX | SELL | 2020-08-07 | $536K | — | Filing → |
| NBIX | SELL | 2020-05-20 | $10.8M | — | Filing → |